Newsroom | 15897 results

Sorted by: Latest

Managed Care
-

Hippocratic AI Named to Newsweek’s America’s Greatest Startup Workplaces 2025

PALO ALTO, Calif.--(BUSINESS WIRE)--Hippocratic AI recognized for excellence in workplace culture and sustainable growth through a rigorous evaluation...
-

Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that 18 abstracts, including one oral presentation, have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025, on April 25 - 30 in Chicago. Tempus researchers will showcase scientific and clinical research that highlight the transformative impact of AI on oncology treatment an...
-

Xevant Unveils 2025 Drug Price Inflation White Paper: A Data-Driven Look at Rising Pharmaceutical Costs and Future Implications

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leading provider of real-time data analytics for pharmacy benefit management, today announced the release of its 2025 Drug Price Inflation White Paper, providing key insights into the ongoing surge in pharmaceutical prices and what it means for payers, employers, and pharmacy benefit managers (PBMs). As the cost of healthcare continues to escalate, the new year has brought a fresh wave of price hikes across the pharmaceutical landscape. Within the first tw...
-

HCA Healthcare Reports First Quarter 2025 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentage changes compare 1Q 2025 to 1Q 2024 unless otherwise noted): Revenues totaled $18.321 billion Net income attributable to HCA Healthcare, Inc. totaled $1.610 billion, or $6.45 per diluted share Adjusted EBITDA totaled $3.733 billion Cash flows from operating activities totaled $1.651 billion Same f...
-

Iksuda to Present Growing ADC Pipeline at AACR

NEWCASTLE, England--(BUSINESS WIRE)--Iksuda Therapeutics (Iksuda), the developer of class leading, clinically validated antibody drug conjugates (ADCs) today announces that it will present three posters at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, Illinois (25-30 April). The posters cover the Company’s new payload class, the ProAlk series, its CA242-directed ADC, IKS04, being developed for the treatment of gastrointestinal (GI) cancers, and its proprietary P...
-

LongOn Capital Announces Acquisition of WeCare Connect by Activated Insights

CUPERTINO, Calif.--(BUSINESS WIRE)--LongOn Capital Announces the Acquisition of its portfolio company, WeCare Connect, by Activated Insights....
-

Premier, Inc. Declares Quarterly Cash Dividend

CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable no later than June 15, 2025, to stockholders of record as of the close of business on June 1, 2025. About Premier, Inc. Premier, Inc. (NASDAQ: PINC) is a leading technology-driven healthcare improvement co...
-

CorWave Announces Successful Completion of 6-Month Chronic In Vivo Study, Paving the Way for Clinical Trial Initiation

CLICHY, France--(BUSINESS WIRE)--CorWave, a medical device company dedicated to the fight against heart failure, announces new preclinical results of its implantable heart pump. CorWave’s in vivo studies demonstrated the pump’s successful operation for six months. Additionally, nine chronic ovine implants were conducted for 60 days, without chronic anticoagulant therapy. There was no device failure during the studies and no sign of thrombosis at explant. The CorWave device operated in pulsatile...
-

TOCCorp Introduces HITMark: Accelerating Capital Project Return on Investment for Healthcare Providers

IRVINE, Calif.--(BUSINESS WIRE)--TOCCorp is proud to announce the launch of HITMark, the first commercially available Software as a Service (SaaS) solution specifically designed for scoping and budgeting healthcare technology, the largest line item for many major capital projects in the healthcare sector. HITMark focuses on infrastructure, medical equipment, clinical applications, business applications, AI, cloud, and security. It is ideal for capital-intensive projects such as construction, me...
-

RestorixHealth Welcomes New C-Suite Leadership

METAIRIE, La.--(BUSINESS WIRE)--RestorixHealth, the nation’s leading wound care solutions company, has announced new corporate leadership in Ben Dunford, MBA, as Chief Executive Officer (CEO) and Melinda Estep, MBA, as Chief Financial Officer (CFO). Dunford brings to RestorixHealth a wealth of healthcare experience serving in various c-suite roles, including CFO at Texas Regional Medical Center at Sunnyvale, Chief Operating Officer (COO) at NorthStar Anesthesia, President of Rural Physicians Gr...